Philips delivered a strong start to 2026 with a 6% increase in comparable order intake and a 4% rise in comparable sales, driven by growth across all segments, especially Personal Health. The company expanded its adjusted EBITA margin by 40 basis points to 9.0%, despite challenges from tariffs and cost inflation, supported by innovation and productivity gains. Philips also secured regulatory approvals for AI-powered health technologies and strengthened strategic partnerships. The company reiterated its full-year 2026 outlook, expecting 3%-4.5% sales growth, a 12.5%-13.0% adjusted EBITA margin, and free cash flow between EUR 1.3-1.5 billion.
The Vanguard Financials ETF (VFH) has received a reiterated buy rating due to its attractive valuation and strong technical momentum as the Q2 earnings season approaches. Trading just above 14 times earnings with a long-term EPS growth near 12%, it o...
The Hoya Capital High Dividend Yield ETF (RIET) provides investors with exposure to high-quality REITs and a high 10.4% dividend yield. However, the fund pays out more than it earns, causing its net asset value (NAV) to decline over time. Its perform...
LAB token soared 173.94% to $16.15, becoming the top gainer in the latest trading session with a market cap of $5.05 billion. This surge reflects growing investor interest in LAB's innovative blockchain solutions. Other notable gainers include Binanc...
Aptos Labs fixed a critical stale-cache bug in its Move virtual machine that could have allowed attackers to manipulate core blockchain data, risking up to $70 billion in assets. Security researchers demonstrated a proof-of-concept exploit with a 90%...
Aptos has fixed a critical vulnerability in its Move virtual machine that could have been exploited for only a few hundred dollars, posing a serious security risk. The flaw was discovered by ethical hackers and patched before any funds were lost or t...
